2m 2m 2m 2m 2m 2m 2m
MAZE THERA (MAZE)
NASDAQ
$30.81+$1.63 (+5.60%)
Price as of Jul 14, 2026 4:02 AM EDT- $1.6BMarket Cap
- 85.39%1-Year Change
- BiotechnologyIndustry
MAZE THERA (MAZE)
$30.81+$1.63 (+5.60%)
MAZE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.18 | ||
Change | -$1.39 (-4.55%) | ||
Open | $30.04 | ||
High | $30.36 | ||
Low | $29.16 | ||
Previous Close | $30.57 | ||
Volume | 508,343 | ||
30-Day Average Volume | 888,930 | ||
1-Week Change | -9.80% | ||
1-Month Change | 21.33% | ||
1-Year Change | 85.39% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 55.3M | ||
Total Assets | $419.7M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$24.2M | ||
Free Cash Flow | -$39.2M | ||
EBIT | -$23.3M | ||
EBITDA | -$22.9M | ||
Net Working Capital | $358.5M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -64 | ||
Enterprise Value/Revenue | 73 | ||
P/B | 5 | ||
P/E | -65 | ||
PEG | -2 | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue